查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1750801

生物样本库市场规模、份额、趋势分析报告：按产品/服务、生物检体类型、生物样本库类型、应用、地区、细分市场、预测，2025-2030 年

Biobanks Market Size, Share & Trends Analysis Report By Product & Services (LIMS, Biobanking Equipment), By Biospecimen Type (Organs, Stem Cells), By Biobanks Type (Real, Virtual), By Application, By Region, And Segment Forecasts, 2025 - 2030
出版日期: | 出版商: Grand View Research | 英文 185 Pages | 商品交期: 2-10个工作天内

价格

生物库市场的成长与趋势：

根据Grand View Research, Inc.的最新报告，全球生物银行市场规模预计到2030年将达到1,266.9亿美元，2025年至2030年期间的复合年增长率为7.85%。

随着NGS等新技术的引入以及人们对基因组医学日益增长的关注，生物样本库也在不断发展。多种生物样本类型可用于药物研发、诊断等多个领域，这加速了生物样本库的多样化发展并推动了市场的发展。生物样本的品质对疾病检测以及临床前和临床研究有重大影响。监管机构透过制定有效样本管理指南，在推动生物银行服务的普及方面发挥关键作用。

例如，美国疾病管制与预防中心（CDC）已发布指南，旨在最大程度地减少处理COVID-19样本过程中的人为危害，这已成为其他生物样本库的典范。此外，随着COVID-19相关研究和临床试验的不断增加，预计在不久的将来对高品质生物样本的需求将大幅增加，从而推动市场成长。此外，生物样本库还促进了基于生物检体资料库研究，以估算实际血清流行率。 Health Catalyst, Inc.透过其Touchstone平台提供与COVID-19相关的全国性资料。预计这些因素将有助于该行业的收益。

BioResource 由 RareCan 于 2021 年 10 月创立，RareCan 是一家位于赫克瑟姆的医疗保健新兴企业，致力于改善罕见癌症的研究。 BioResource 保存着癌症患者手术后采集的样本，并将其提供给世界各地的研究人员，用于治疗、预防和识别疾病。 2021 年 12 月，纽卡斯尔大学推出了新的人体血液样本和人体组织捐赠库。英国生物样本库宣布，资料库新增了一项测量一系列循环代谢体学学生物标记的研究数据。南丁格尔健康公司是一家专注于血液生物标记技术的芬兰公司，对 12 万名参与者进行了这项研究。

此外，美国新冠病例激增以及研发项目的增加，促使新的生物样本库建立，从而推动了北美市场的收益。随着亚洲国家製药和临床研究领域的持续扩张，亚太地区市场预计将实现最快成长。主要企业正努力透过与全球经销商合作、与其他公司併购以及与研究机构建立策略联盟来扩大其全球影响力。

生物样本库市场报告重点

  • 由于生物库数量的增加和设备高成本，生物银行设备部门在 2024 年占据了最大的收入份额。
  • 预计生物银行和储存库服务部门将在 2024 年占据最大的收益占有率，这得益于这些服务的高渗透率以及精准医疗和特异性疾病研发对保存生物样本的需求不断增长。
  • 人体组织是临床研究中最常见的储存样本，因此这种样本类型占据市场主导地位。
  • 由于生物医学研究对罕见疾病数据的需求以及对 3D 生物样本的需求不断增长，预计虚拟生物库部分将在预测期内实现最快的复合年增长率。
  • 2024 年，由于细胞疗法在癌症治疗中的日益普及，治疗药物应用领域将占据最大的收益占有率。
  • 私人製药和生物技术公司已经建立了私人银行来支持临床试验和细胞疗法开发，从而增加了该领域的企业收益。

目录

第一章调查方法与范围

第二章执行摘要

第三章生物样本库市场变数、趋势与范围

  • 市场展望
    • 母市场展望
    • 相关/附随市场展望
  • 市场动态
    • 市场驱动因素分析
    • 市场限制因素分析
  • 生物库市场分析工具
    • 产业分析-波特五力分析
    • PESTEL分析

第四章生物库市场：按产品/服务的估计和趋势分析

  • 细分仪表板
  • 2024 年和 2030 年按产品和服务分類的市场占有率
  • 产品
  • 2018年至2030年市场规模、预测及趋势分析
    • 生物库设备
    • 生物银行耗材
    • 实验室资讯管理系统
  • 服务
  • 2018年至2030年市场规模、预测及趋势分析
    • 生物银行和储存库
    • 实验室处理
    • 资格/检验
    • 低温运输物流
    • 其他服务

第五章生物样本库市场：按生物检体类型进行的估计和趋势分析

  • 细分仪表板
  • 2024 年和 2030 年生物检体类型市场占有率
  • 2018年至2030年市场规模、预测及趋势分析
    • 人体组织
    • 人体器官
    • 干细胞
    • 其他生物标本

第六章生物样本库市场：依生物样本库类型估算与趋势分析

  • 细分仪表板
  • 2024 年及 2030 年生物样本库市场占有率（按类型）
  • 2018年至2030年市场规模、预测及趋势分析
    • 实体/真实生物样本库
    • 虚拟生物库

第七章生物库市场：按应用的估计和趋势分析

  • 细分仪表板
  • 2024 年及 2030 年各应用领域的市场占有率
  • 2018年至2030年市场规模、预测及趋势分析
    • 治疗
    • 药物研发与临床研究
    • 临床诊断
    • 其他用途

第八章生物样本库市场：按地区估计和趋势分析

  • 区域市场仪表板
  • 2024 年及 2030 年区域市场占有率分析
  • 2018-2030年市场规模、预测趋势分析
  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 英国
    • 德国
    • 法国
    • 义大利
    • 西班牙
    • 挪威
    • 瑞典
    • 丹麦
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 韩国
    • 泰国
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中东和非洲
    • 南非
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 科威特

第九章 竞争态势

  • 公司/竞争对手分类
  • 战略地图
  • 2024年企业市场分析
  • 公司简介/上市公司
    • Thermo Fisher Scientific Inc.
    • Merck KGaA
    • Qiagen
    • Hamilton Company
    • Tecan Trading AG
    • Danaher Corporation
    • Becton, Dickinson, and Company（BD）
    • Biocision, LLC.
    • Taylor-Wharton
    • Charles River Laboratories
    • Lonza
    • Stemcell Technologies
    • Biovault Family
    • Promocell GmbH
    • Precision Cellular Storage Ltd.（Virgin Health Bank）
Product Code: GVR-2-68038-564-9

Biobanks Market Growth & Trends:

The global biobanks market size is expected to reach USD 126.69 billion in 2030 and is expected to grow at a CAGR of 7.85% from 2025 to 2030, according to a new report by Grand View Research, Inc. Biobanks continue to evolve with the introduction of new technologies, such as NGS, and increased focus on genomic medicine. The availability of several types of biospecimens to cater to multiple domains including drug discovery, diagnostics, and others has accelerated the diversification of biorepositories, thereby driving the market. The quality of biospecimens can significantly influence disease testing as well as preclinical and clinical research. Regulatory agencies have played a vital role in spurring the adoption of biobanking services by establishing guidelines for the effective management of samples.

For instance, the U.S. Centers for Disease Control and Prevention (CDC) released guidelines to minimize human hazards while handling COVID-19 samples. This serves as a model for other biorepositories. Furthermore, as the number of research studies and clinical trials related to COVID-19 is increasing, the demand for high-quality biospecimens is expected to significantly increase in the near future, leading to market growth. In addition, population-based cohort studies are facilitated by biorepositories to estimate the actual seroprevalence. Health Catalyst, Inc., through its Touchstone platform, provides national data related to COVID-19 insights. Such factors are anticipated to contribute to the revenue flow in this space.

The 'BioResource' was created in October 2021 by RareCan, a Hexham-based healthcare start-up dedicated to improving studies into the uncommon forms of cancer. BioResource will retain samples taken after surgery from cancer patients and make them accessible to researchers across the globe who can use them to cure, prevent, and identify the disease. In December 2021, Newcastle University introduced a new collection of human blood samples and donated human tissue, which could transform efforts to cure rare cancers. The U.K. Biobank has announced that fresh data from a study measuring the range of circulatory metabolomics biomarkers has been added to its database. Nightingale Health, a Finnish business specializing in blood biomarker technologies, conducted the study with 120000 participants.

North America dominated the market with its wide network of centers for biosample storage in the U.S. Moreover, a high number of COVID-19 cases in the U.S. and increased R&D programs have resulted in the establishment of new biorepositories, thereby driving revenue in North America. In Asia Pacific, the market is anticipated to register the fastest growth owing to the ever-expanding pharmaceuticals and clinical research domain across Asian countries. The key players are engaged in expanding their global reach by partnering with global distributors, mergers, and acquisitions of other players, and entering a strategic alliance with research communities.

Biobanks Market Report Highlights:

  • The biobanking equipment segment accounted for the maximum revenue share in 2024 owing to the high cost of instruments coupled with an increase in the number of biorepositories
  • The biobanking and repository services segment accounted for the largest revenue share in 2024 due to the higher penetration of these services and the increased need for the preservation of biosamples for developing precision medicine and disease-specific research
  • Human tissues are the most stored sample for clinical research, resulting in the dominance of this sample type in the market
  • The virtual biobanks segment is anticipated to witness the fastest CAGR during the forecast period owing to the growing demand for 3D biospecimens coupled with the need for rare disease data for biomedical research
  • The therapeutics application segment accounted for the largest revenue share in 2024 owing to the growing popularity of cell therapies for cancer treatment
  • Several pharma/biotech companies have established their private banks to support clinical trials and the development of cell therapies, resulting in revenue growth in this segment.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Product & Services
    • 1.2.2. Biospecimen Type
    • 1.2.3. Biobanks Type
    • 1.2.4. Application
  • 1.3. Research Methodology
  • 1.4. Information Procurement
  • 1.5. Information or Data Analysis
    • 1.5.1. Data analysis models
  • 1.6. Market Formulation & Validation
  • 1.7. List of Secondary Sources
  • 1.8. List of Primary Sources
  • 1.9. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
  • 2.3. Competitive Insights

Chapter 3. Biobanks Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market driver analysis
      • 3.2.1.1. Continuous increase in COVID-19 cases along with capacity expansion
      • 3.2.1.2. Increased focus on precision medicine and genetic testing
      • 3.2.1.3. Changes in biobanking operations
      • 3.2.1.4. Increase in the number of clinical trials globally
      • 3.2.1.5. Growing industry and research collaborations
      • 3.2.1.6. Technology advancement and automation
    • 3.2.2. Market restraint analysis
      • 3.2.2.1. Disruptions in supply chain management due to COVID-19
      • 3.2.2.2. Challenges in sharing biobanking data & limited access to biospecimens
      • 3.2.2.3. Sustainability challenges for biobanks
      • 3.2.2.4. Other challenges in biobanking specimens for research
  • 3.3. Biobanks Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
    • 3.3.2. PESTEL Analysis

Chapter 4. Biobanks Market: Product & Services Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. Product & Services Market Share, 2024 & 2030
  • 4.3. Product
  • 4.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
    • 4.4.1. Biobank Equipment
      • 4.4.1.1. Market estimates and forecasts 2018 to 2030 (USD Million)
      • 4.4.1.2. Temperature Control Systems
        • 4.4.1.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
        • 4.4.1.2.2. Freezers & Refrigerators
          • 4.4.1.2.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
        • 4.4.1.2.3. Cryogenic Storage Systems
        • 4.4.1.2.4. Market estimates and forecasts 2018 to 2030 (USD Million)
        • 4.4.1.2.5. Thawing Equipment
        • 4.4.1.2.6. Market estimates and forecasts 2018 to 2030 (USD Million)
      • 4.4.1.3. Incubators & Centrifuges
        • 4.4.1.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
      • 4.4.1.4. Alarms & Monitoring Systems
        • 4.4.1.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
      • 4.4.1.5. Accessories & Other Equipment
        • 4.4.1.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.4.2. Biobanking Consumables
      • 4.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.4.3. Laboratory Information Management Systems
      • 4.4.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.5. Services
  • 4.6. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
    • 4.6.1. Biobanking & repository
      • 4.6.1.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.6.2. Lab processing
      • 4.6.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.6.3. Qualification/ Validation
      • 4.6.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.6.4. Cold Chain Logistics
      • 4.6.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.6.5. Other Services
      • 4.6.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 5. Biobanks Market: Biospecimen Type Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. Biospecimen Type Market Share, 2024 & 2030
  • 5.3. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
    • 5.3.1. Human Tissues
      • 5.3.1.1. Market estimates and forecasts 2018 to 2030 (USD million)
    • 5.3.2. Human Organs
      • 5.3.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.3.3. Stem Cells
      • 5.3.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
      • 5.3.3.2. Adult Stem Cells
        • 5.3.3.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
      • 5.3.3.3. Embryonic Stem Cells
        • 5.3.3.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
      • 5.3.3.4. IPS Cells
        • 5.3.3.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
      • 5.3.3.5. Other Stem Cells
        • 5.3.3.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.3.4. Other biospecimens
      • 5.3.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 6. Biobanks Market: Biobanks Type Estimates & Trend Analysis

  • 6.1. Segment Dashboard
  • 6.2. Biobanks Type Market Share, 2024 & 2030
  • 6.3. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
    • 6.3.1. Physical/Real biobanks
      • 6.3.1.1. Market estimates and forecasts 2018 to 2030 (USD million)
      • 6.3.1.2. Tissue Biobanks
        • 6.3.1.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
      • 6.3.1.3. Population based biobanks
        • 6.3.1.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
      • 6.3.1.4. Genetic (DNA/RNA)
        • 6.3.1.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
      • 6.3.1.5. Disease based biobanks
        • 6.3.1.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.3.2. Virtual biobanks
      • 6.3.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 7. Biobanks Market: Application Estimates & Trend Analysis

  • 7.1. Segment Dashboard
  • 7.2. Application Market Share, 2024 & 2030
  • 7.3. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
    • 7.3.1. Therapeutics
      • 7.3.1.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.3.2. Drug discovery & clinical research
      • 7.3.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.3.3. Clinical Diagnostics
      • 7.3.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.3.4. Other Applications
      • 7.3.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 8. Biobanks Market: Regional Estimates & Trend Analysis

  • 8.1. Regional Market Dashboard
  • 8.2. Regional Market Share Analysis, 2024 & 2030
  • 8.3. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
  • 8.4. North America
    • 8.4.1. U.S.
      • 8.4.1.1. Key country dynamics
      • 8.4.1.2. Regulatory framework/ reimbursement structure
      • 8.4.1.3. Competitive scenario
      • 8.4.1.4. U.S. market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.4.2. Canada
      • 8.4.2.1. Key country dynamics
      • 8.4.2.2. Regulatory framework/ reimbursement structure
      • 8.4.2.3. Competitive scenario
      • 8.4.2.4. Canada market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.4.3. Mexico
      • 8.4.3.1. Key country dynamics
      • 8.4.3.2. Regulatory framework/ reimbursement structure
      • 8.4.3.3. Competitive scenario
      • 8.4.3.4. Mexico market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.5. Europe
    • 8.5.1. UK
      • 8.5.1.1. Key country dynamics
      • 8.5.1.2. Regulatory framework/ reimbursement structure
      • 8.5.1.3. Competitive scenario
      • 8.5.1.4. UK market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.5.2. Germany
      • 8.5.2.1. Key country dynamics
      • 8.5.2.2. Regulatory framework/ reimbursement structure
      • 8.5.2.3. Competitive scenario
      • 8.5.2.4. Germany market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.5.3. France
      • 8.5.3.1. Key country dynamics
      • 8.5.3.2. Regulatory framework/ reimbursement structure
      • 8.5.3.3. Competitive scenario
      • 8.5.3.4. France market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.5.4. Italy
      • 8.5.4.1. Key country dynamics
      • 8.5.4.2. Regulatory framework/ reimbursement structure
      • 8.5.4.3. Competitive scenario
      • 8.5.4.4. Italy market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.5.5. Spain
      • 8.5.5.1. Key country dynamics
      • 8.5.5.2. Regulatory framework/ reimbursement structure
      • 8.5.5.3. Competitive scenario
      • 8.5.5.4. Spain market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.5.6. Norway
      • 8.5.6.1. Key country dynamics
      • 8.5.6.2. Regulatory framework/ reimbursement structure
      • 8.5.6.3. Competitive scenario
      • 8.5.6.4. Norway market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.5.7. Sweden
      • 8.5.7.1. Key country dynamics
      • 8.5.7.2. Regulatory framework/ reimbursement structure
      • 8.5.7.3. Competitive scenario
      • 8.5.7.4. Sweden market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.5.8. Denmark
      • 8.5.8.1. Key country dynamics
      • 8.5.8.2. Regulatory framework/ reimbursement structure
      • 8.5.8.3. Competitive scenario
      • 8.5.8.4. Denmark market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.6. Asia Pacific
    • 8.6.1. Japan
      • 8.6.1.1. Key country dynamics
      • 8.6.1.2. Regulatory framework/ reimbursement structure
      • 8.6.1.3. Competitive scenario
      • 8.6.1.4. Japan market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.6.2. China
      • 8.6.2.1. Key country dynamics
      • 8.6.2.2. Regulatory framework/ reimbursement structure
      • 8.6.2.3. Competitive scenario
      • 8.6.2.4. China market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.6.3. India
      • 8.6.3.1. Key country dynamics
      • 8.6.3.2. Regulatory framework/ reimbursement structure
      • 8.6.3.3. Competitive scenario
      • 8.6.3.4. India market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.6.4. Australia
      • 8.6.4.1. Key country dynamics
      • 8.6.4.2. Regulatory framework/ reimbursement structure
      • 8.6.4.3. Competitive scenario
      • 8.6.4.4. Australia market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.6.5. South Korea
      • 8.6.5.1. Key country dynamics
      • 8.6.5.2. Regulatory framework/ reimbursement structure
      • 8.6.5.3. Competitive scenario
      • 8.6.5.4. South Korea market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.6.6. Thailand
      • 8.6.6.1. Key country dynamics
      • 8.6.6.2. Regulatory framework/ reimbursement structure
      • 8.6.6.3. Competitive scenario
      • 8.6.6.4. Thailand market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.7. Latin America
    • 8.7.1. Brazil
      • 8.7.1.1. Key country dynamics
      • 8.7.1.2. Regulatory framework/ reimbursement structure
      • 8.7.1.3. Competitive scenario
      • 8.7.1.4. Brazil market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.7.2. Argentina
      • 8.7.2.1. Key country dynamics
      • 8.7.2.2. Regulatory framework/ reimbursement structure
      • 8.7.2.3. Competitive scenario
      • 8.7.2.4. Argentina market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.8. MEA
    • 8.8.1. South Africa
      • 8.8.1.1. Key country dynamics
      • 8.8.1.2. Regulatory framework/ reimbursement structure
      • 8.8.1.3. Competitive scenario
      • 8.8.1.4. South Africa market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.8.2. Saudi Arabia
      • 8.8.2.1. Key country dynamics
      • 8.8.2.2. Regulatory framework/ reimbursement structure
      • 8.8.2.3. Competitive scenario
      • 8.8.2.4. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.8.3. UAE
      • 8.8.3.1. Key country dynamics
      • 8.8.3.2. Regulatory framework/ reimbursement structure
      • 8.8.3.3. Competitive scenario
      • 8.8.3.4. UAE market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.8.4. Kuwait
      • 8.8.4.1. Key country dynamics
      • 8.8.4.2. Regulatory framework/ reimbursement structure
      • 8.8.4.3. Competitive scenario
      • 8.8.4.4. Kuwait market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 9. Competitive Landscape

  • 9.1. Company/Competition Categorization
  • 9.2. Strategy Mapping
  • 9.3. Company Market Position Analysis, 2024
  • 9.4. Company Profiles/Listing
    • 9.4.1. Thermo Fisher Scientific Inc.
      • 9.4.1.1. Company overview
      • 9.4.1.2. Financial performance
      • 9.4.1.3. Product benchmarking
      • 9.4.1.4. Strategic initiatives
    • 9.4.2. Merck KGaA
      • 9.4.2.1. Company overview
      • 9.4.2.2. Financial performance
      • 9.4.2.3. Product benchmarking
      • 9.4.2.4. Strategic initiatives
    • 9.4.3. Qiagen
      • 9.4.3.1. Company overview
      • 9.4.3.2. Financial performance
      • 9.4.3.3. Product benchmarking
      • 9.4.3.4. Strategic initiatives
    • 9.4.4. Hamilton Company
      • 9.4.4.1. Company overview
      • 9.4.4.2. Financial performance
      • 9.4.4.3. Product benchmarking
      • 9.4.4.4. Strategic initiatives
    • 9.4.5. Tecan Trading AG
      • 9.4.5.1. Company overview
      • 9.4.5.2. Financial performance
      • 9.4.5.3. Product benchmarking
      • 9.4.5.4. Strategic initiatives
    • 9.4.6. Danaher Corporation
      • 9.4.6.1. Company overview
      • 9.4.6.2. Financial performance
      • 9.4.6.3. Product benchmarking
      • 9.4.6.4. Strategic initiatives
    • 9.4.7. Becton, Dickinson, and Company (BD)
      • 9.4.7.1. Company overview
      • 9.4.7.2. Financial performance
      • 9.4.7.3. Product benchmarking
      • 9.4.7.4. Strategic initiatives
    • 9.4.8. Biocision, LLC.
      • 9.4.8.1. Company overview
      • 9.4.8.2. Financial performance
      • 9.4.8.3. Product benchmarking
      • 9.4.8.4. Strategic initiatives
    • 9.4.9. Taylor-Wharton
      • 9.4.9.1. Company overview
      • 9.4.9.2. Financial performance
      • 9.4.9.3. Product benchmarking
      • 9.4.9.4. Strategic initiatives
    • 9.4.10. Charles River Laboratories
      • 9.4.10.1. Company overview
      • 9.4.10.2. Financial performance
      • 9.4.10.3. Product benchmarking
      • 9.4.10.4. Strategic initiatives
    • 9.4.11. Lonza
      • 9.4.11.1. Company overview
      • 9.4.11.2. Financial performance
      • 9.4.11.3. Product benchmarking
      • 9.4.11.4. Strategic initiatives
    • 9.4.12. Stemcell Technologies
      • 9.4.12.1. Company overview
      • 9.4.12.2. Financial performance
      • 9.4.12.3. Product benchmarking
      • 9.4.12.4. Strategic initiatives
    • 9.4.13. Biovault Family
      • 9.4.13.1. Company overview
      • 9.4.13.2. Financial performance
      • 9.4.13.3. Product benchmarking
      • 9.4.13.4. Strategic initiatives
    • 9.4.14. Promocell GmbH
      • 9.4.14.1. Company overview
      • 9.4.14.2. Financial performance
      • 9.4.14.3. Product benchmarking
      • 9.4.14.4. Strategic initiatives
    • 9.4.15. Precision Cellular Storage Ltd. (Virgin Health Bank)
      • 9.4.15.1. Company overview
      • 9.4.15.2. Financial performance
      • 9.4.15.3. Product benchmarking
      • 9.4.15.4. Strategic initiatives

List of Tables

  • Table 1 List of abbreviation
  • Table 2 North America biobanks market, by region, 2018 - 2030 (USD Million)
  • Table 3 North America biobanks market, by product & services, 2018 - 2030 (USD Million)
  • Table 4 North America biobanks market, by biospecimen type, 2018 - 2030 (USD Million)
  • Table 5 North America biobanks market, by biobanks type, 2018 - 2030 (USD Million)
  • Table 6 North America biobanks market, by application, 2018 - 2030 (USD Million)
  • Table 7 U.S. biobanks market, by product & services, 2018 - 2030 (USD Million)
  • Table 8 U.S. biobanks market, by biospecimen type, 2018 - 2030 (USD Million)
  • Table 9 U.S. biobanks market, by biobanks type, 2018 - 2030 (USD Million)
  • Table 10 U.S. biobanks market, by application, 2018 - 2030 (USD Million)
  • Table 11 Mexico biobanks market, by product & services, 2018 - 2030 (USD Million)
  • Table 12 Mexico biobanks market, by biospecimen type, 2018 - 2030 (USD Million)
  • Table 13 Mexico biobanks market, by biobanks type, 2018 - 2030 (USD Million)
  • Table 14 Mexico biobanks market, by application, 2018 - 2030 (USD Million)
  • Table 15 Canada biobanks market, by product & services, 2018 - 2030 (USD Million)
  • Table 16 Canada biobanks market, by biospecimen type, 2018 - 2030 (USD Million)
  • Table 17 Canada biobanks market, by biobanks type, 2018 - 2030 (USD Million)
  • Table 18 Canada biobanks market, by application, 2018 - 2030 (USD Million)
  • Table 19 Europe biobanks market, by region, 2018 - 2030 (USD Million)
  • Table 20 Europe biobanks market, by product & services, 2018 - 2030 (USD Million)
  • Table 21 Europe biobanks market, by biospecimen type, 2018 - 2030 (USD Million)
  • Table 22 Europe biobanks market, by biobanks type, 2018 - 2030 (USD Million)
  • Table 23 Europe biobanks market, by application, 2018 - 2030 (USD Million)
  • Table 24 Germany biobanks market, by product & services, 2018 - 2030 (USD Million)
  • Table 25 Germany biobanks market, by biospecimen type, 2018 - 2030 (USD Million)
  • Table 26 Germany biobanks market, by biobanks type, 2018 - 2030 (USD Million)
  • Table 27 Germany biobanks market, by application, 2018 - 2030 (USD Million)
  • Table 28 UK biobanks market, by product & services, 2018 - 2030 (USD Million)
  • Table 29 UK biobanks market, by biospecimen type, 2018 - 2030 (USD Million)
  • Table 30 UK biobanks market, by biobanks type, 2018 - 2030 (USD Million)
  • Table 31 UK biobanks market, by application, 2018 - 2030 (USD Million)
  • Table 32 France biobanks market, by product & services, 2018 - 2030 (USD Million)
  • Table 33 France biobanks market, by biospecimen type, 2018 - 2030 (USD Million)
  • Table 34 France biobanks market, by biobanks type, 2018 - 2030 (USD Million)
  • Table 35 France biobanks market, by application, 2018 - 2030 (USD Million)
  • Table 36 Italy biobanks market, by product & services, 2018 - 2030 (USD Million)
  • Table 37 Italy biobanks market, by biospecimen type, 2018 - 2030 (USD Million)
  • Table 38 Italy biobanks market, by biobanks type, 2018 - 2030 (USD Million)
  • Table 39 Italy biobanks market, by application, 2018 - 2030 (USD Million)
  • Table 40 Spain biobanks market, by product & services, 2018 - 2030 (USD Million)
  • Table 41 Spain biobanks market, by biospecimen type, 2018 - 2030 (USD Million)
  • Table 42 Spain biobanks market, by biobanks type, 2018 - 2030 (USD Million)
  • Table 43 Spain biobanks market, by application, 2018 - 2030 (USD Million)
  • Table 44 Denmark biobanks market, by product & services, 2018 - 2030 (USD Million)
  • Table 45 Denmark biobanks market, by biospecimen type, 2018 - 2030 (USD Million)
  • Table 46 Denmark biobanks market, by biobanks type, 2018 - 2030 (USD Million)
  • Table 47 Denmark biobanks market, by application, 2018 - 2030 (USD Million)
  • Table 48 Sweden biobanks market, by product & services, 2018 - 2030 (USD Million)
  • Table 49 Sweden biobanks market, by biospecimen type, 2018 - 2030 (USD Million)
  • Table 50 Sweden biobanks market, by biobanks type, 2018 - 2030 (USD Million)
  • Table 51 Sweden biobanks market, by application, 2018 - 2030 (USD Million)
  • Table 52 Norway biobanks market, by product & services, 2018 - 2030 (USD Million)
  • Table 53 Norway biobanks market, by biospecimen type, 2018 - 2030 (USD Million)
  • Table 54 Norway biobanks market, by biobanks type, 2018 - 2030 (USD Million)
  • Table 55 Norway biobanks market, by application, 2018 - 2030 (USD Million)
  • Table 56 Asia Pacific biobanks market, by region, 2018 - 2030 (USD Million)
  • Table 57 Asia Pacific biobanks market, by product & services, 2018 - 2030 (USD Million)
  • Table 58 Asia Pacific biobanks market, by biospecimen type, 2018 - 2030 (USD Million)
  • Table 59 Asia Pacific biobanks market, by biobanks type, 2018 - 2030 (USD Million)
  • Table 60 Asia Pacific biobanks market, by application, 2018 - 2030 (USD Million)
  • Table 61 China biobanks market, by product & services, 2018 - 2030 (USD Million)
  • Table 62 China biobanks market, by biospecimen type, 2018 - 2030 (USD Million)
  • Table 63 China biobanks market, by biobanks type, 2018 - 2030 (USD Million)
  • Table 64 China biobanks market, by application, 2018 - 2030 (USD Million)
  • Table 65 Japan biobanks market, by product & services, 2018 - 2030 (USD Million)
  • Table 66 Japan biobanks market, by biospecimen type, 2018 - 2030 (USD Million)
  • Table 67 Japan biobanks market, by biobanks type, 2018 - 2030 (USD Million)
  • Table 68 Japan biobanks market, by application, 2018 - 2030 (USD Million)
  • Table 69 India biobanks market, by product & services, 2018 - 2030 (USD Million)
  • Table 70 India biobanks market, by biospecimen type, 2018 - 2030 (USD Million)
  • Table 71 India biobanks market, by biobanks type, 2018 - 2030 (USD Million)
  • Table 72 India biobanks market, by application, 2018 - 2030 (USD Million)
  • Table 73 South Korea biobanks market, by product & services, 2018 - 2030 (USD Million)
  • Table 74 South Korea biobanks market, by biospecimen type, 2018 - 2030 (USD Million)
  • Table 75 South Korea biobanks market, by biobanks type, 2018 - 2030 (USD Million)
  • Table 76 South Korea biobanks market, by application, 2018 - 2030 (USD Million)
  • Table 77 Australia biobanks market, by product & services, 2018 - 2030 (USD Million)
  • Table 78 Australia biobanks market, by biospecimen type, 2018 - 2030 (USD Million)
  • Table 79 Australia biobanks market, by biobanks type, 2018 - 2030 (USD Million)
  • Table 80 Australia biobanks market, by application, 2018 - 2030 (USD Million)
  • Table 81 Thailand biobanks market, by product & services, 2018 - 2030 (USD Million)
  • Table 82 Thailand biobanks market, by biospecimen type, 2018 - 2030 (USD Million)
  • Table 83 Thailand biobanks market, by biobanks type, 2018 - 2030 (USD Million)
  • Table 84 Thailand biobanks market, by application, 2018 - 2030 (USD Million)
  • Table 85 Latin America biobanks market, by product & services, 2018 - 2030 (USD Million)
  • Table 86 Latin America biobanks market, by biospecimen type, 2018 - 2030 (USD Million)
  • Table 87 Latin America biobanks market, by biobanks type, 2018 - 2030 (USD Million)
  • Table 88 Latin America biobanks market, by application, 2018 - 2030 (USD Million)
  • Table 89 Brazil biobanks market, by product & services, 2018 - 2030 (USD Million)
  • Table 90 Brazil biobanks market, by biospecimen type, 2018 - 2030 (USD Million)
  • Table 91 Brazil biobanks market, by biobanks type, 2018 - 2030 (USD Million)
  • Table 92 Brazil biobanks market, by application, 2018 - 2030 (USD Million)
  • Table 93 Argentina biobanks market, by product & services, 2018 - 2030 (USD Million)
  • Table 94 Argentina biobanks market, by biospecimen type, 2018 - 2030 (USD Million)
  • Table 95 Argentina biobanks market, by biobanks type, 2018 - 2030 (USD Million)
  • Table 96 Argentina biobanks market, by application, 2018 - 2030 (USD Million)
  • Table 97 MEA biobanks market, by region, 2018 - 2030 (USD Million)
  • Table 98 MEA biobanks market, by product & services, 2018 - 2030 (USD Million)
  • Table 99 MEA biobanks market, by biospecimen type, 2018 - 2030 (USD Million)
  • Table 100 MEA biobanks market, by biobanks type, 2018 - 2030 (USD Million)
  • Table 101 MEA biobanks market, by application, 2018 - 2030 (USD Million)
  • Table 102 South Africa biobanks market, by product & services, 2018 - 2030 (USD Million)
  • Table 103 South Africa biobanks market, by biospecimen type, 2018 - 2030 (USD Million)
  • Table 104 South Africa biobanks market, by biobanks type, 2018 - 2030 (USD Million)
  • Table 105 South Africa biobanks market, by application, 2018 - 2030 (USD Million)
  • Table 106 Saudi Arabia biobanks market, by product & services, 2018 - 2030 (USD Million)
  • Table 107 Saudi Arabia biobanks market, by biospecimen type, 2018 - 2030 (USD Million)
  • Table 108 Saudi Arabia biobanks market, by biobanks type, 2018 - 2030 (USD Million)
  • Table 109 Saudi Arabia biobanks market, by application, 2018 - 2030 (USD Million)
  • Table 110 UAE biobanks market, by product & services, 2018 - 2030 (USD Million)
  • Table 111 UAE biobanks market, by biospecimen type, 2018 - 2030 (USD Million)
  • Table 112 UAE biobanks market, by biobanks type, 2018 - 2030 (USD Million)
  • Table 113 UAE biobanks market, by application, 2018 - 2030 (USD Million)
  • Table 114 Kuwait biobanks market, by product & services, 2018 - 2030 (USD Million)
  • Table 115 Kuwait biobanks market, by biospecimen type, 2018 - 2030 (USD Million)
  • Table 116 Kuwait biobanks market, by biobanks type, 2018 - 2030 (USD Million)
  • Table 117 Kuwait biobanks market, by application, 2018 - 2030 (USD Million)

List of Tables

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Primary research pattern
  • Fig. 4 Market research approaches
  • Fig. 5 Value-chain-based sizing & forecasting
  • Fig. 6 QFD modeling for market share assessment
  • Fig. 7 Market formulation & validation
  • Fig. 8 Biobanks market: market outlook
  • Fig. 9 Biobanks competitive insights
  • Fig. 10 Parent market outlook
  • Fig. 11 Related/ancillary market outlook
  • Fig. 12 Penetration and growth prospect mapping
  • Fig. 13 Industry value chain analysis
  • Fig. 14 Biobanks market driver impact
  • Fig. 15 Biobanks market restraint impact
  • Fig. 16 Biobanks market strategic initiatives analysis
  • Fig. 17 Biobanks market: Product & services movement analysis
  • Fig. 18 Biobanks market: Product & services outlook and key takeaways
  • Fig. 19 Product market estimates and forecast, 2018 - 2030
  • Fig. 20 Biobanking equipment market estimates and forecast, 2018 - 2030
  • Fig. 21 Temperature control systems estimates and forecast, 2018 - 2030
  • Fig. 22 Freezers & refrigerators market estimates and forecast, 2018 - 2030
  • Fig. 23 Cryogenic storage systems market estimates and forecast, 2018 - 2030
  • Fig. 24 Thawing equipment market estimates and forecast, 2018 - 2030
  • Fig. 25 Incubators & centrifuges market estimates and forecast, 2018 - 2030
  • Fig. 26 Alarms & monitoring systems market estimates and forecast, 2018 - 2030
  • Fig. 27 Accessories & other equipment market estimates and forecast, 2018 - 2030
  • Fig. 28 Biobanking consumables market estimates and forecast, 2018 - 2030
  • Fig. 29 Laboratory information management systems market estimates and forecast, 2018 - 2030
  • Fig. 30 Services market estimates and forecasts, 2018 - 2030
  • Fig. 31 Biobanking & repository market estimates and forecasts, 2018 - 2030
  • Fig. 32 Lab processing market estimates and forecasts,2018 - 2030
  • Fig. 33 Qualification/ Validation market estimates and forecasts,2018 - 2030
  • Fig. 34 Cold chain logistics market estimates and forecasts, 2018 - 2030
  • Fig. 35 Other services market estimates and forecasts,2018 - 2030
  • Fig. 36 Biobanks market: Biospecimen type movement analysis
  • Fig. 37 Biobanks market: Biospecimen type outlook and key takeaways
  • Fig. 38 Human tissues market estimates and forecasts, 2018 - 2030
  • Fig. 39 Human organs market estimates and forecasts,2018 - 2030
  • Fig. 40 Stem cells market estimates and forecasts, 2018 - 2030
  • Fig. 41 Adult stem cells market estimates and forecasts,2018 - 2030
  • Fig. 42 Embryonic stem cells market estimates and forecasts, 2018 - 2030
  • Fig. 43 IPS cells market estimates and forecasts, 2018 - 2030
  • Fig. 44 Other stem cells market estimates and forecasts, 2018 - 2030
  • Fig. 45 Other biospecimens market estimates and forecasts, 2018 - 2030
  • Fig. 46 Biobanks market: Biobanks type movement analysis
  • Fig. 47 Biobanks market: Biobanks type outlook and key takeaways
  • Fig. 48 Physical/Real biobanks market estimates and forecasts, 2018 - 2030
  • Fig. 49 Tissue biobanks market estimates and forecasts,2018 - 2030
  • Fig. 50 Population based biobanks market estimates and forecasts, 2018 - 2030
  • Fig. 51 Genetic (DNA/RNA) market estimates and forecasts,2018 - 2030
  • Fig. 52 Disease based biobanks market estimates and forecasts, 2018 - 2030
  • Fig. 53 Virtual biobanks market estimates and forecasts, 2018 - 2030
  • Fig. 54 Biobanks market: Application movement analysis
  • Fig. 55 Biobanks market: Application outlook and key takeaways
  • Fig. 56 Therapeutics market estimates and forecasts, 2018 - 2030
  • Fig. 57 Drug discovery & clinical research market estimates and forecasts,2018 - 2030
  • Fig. 58 Clinical diagnostics market estimates and forecasts, 2018 - 2030
  • Fig. 59 Other applications market estimates and forecasts,2018 - 2030
  • Fig. 60 Global Biobanks market: Regional movement analysis
  • Fig. 61 Global Biobanks market: Regional outlook and key takeaways
  • Fig. 62 North America, by country
  • Fig. 63 North America
  • Fig. 64 North America market estimates and forecasts, 2018 - 2030
  • Fig. 65 U.S. country dynamics
  • Fig. 66 U.S. market estimates and forecasts, 2018 - 2030
  • Fig. 67 Canada country dynamics
  • Fig. 68 Canada market estimates and forecasts, 2018 - 2030
  • Fig. 69 Mexico country dynamics
  • Fig. 70 Mexico market estimates and forecasts, 2018 - 2030
  • Fig. 71 Europe market estimates and forecasts, 2018 - 2030
  • Fig. 72 UK country dynamics
  • Fig. 73 UK market estimates and forecasts, 2018 - 2030
  • Fig. 74 Germany country dynamics
  • Fig. 75 Germany market estimates and forecasts, 2018 - 2030
  • Fig. 76 France country dynamics
  • Fig. 77 France market estimates and forecasts, 2018 - 2030
  • Fig. 78 Italy country dynamics
  • Fig. 79 Italy market estimates and forecasts, 2018 - 2030
  • Fig. 80 Spain country dynamics
  • Fig. 81 Spain market estimates and forecasts, 2018 - 2030
  • Fig. 82 Denmark country dynamics
  • Fig. 83 Denmark market estimates and forecasts, 2018 - 2030
  • Fig. 84 Sweden country dynamics
  • Fig. 85 Sweden market estimates and forecasts, 2018 - 2030
  • Fig. 86 Norway country dynamics
  • Fig. 87 Norway market estimates and forecasts, 2018 - 2030
  • Fig. 88 Asia Pacific market estimates and forecasts, 2018 - 2030
  • Fig. 89 China country dynamics
  • Fig. 90 China market estimates and forecasts, 2018 - 2030
  • Fig. 91 Japan country dynamics
  • Fig. 92 Japan market estimates and forecasts, 2018 - 2030
  • Fig. 93 India country dynamics
  • Fig. 94 India market estimates and forecasts, 2018 - 2030
  • Fig. 95 Thailand country dynamics
  • Fig. 96 Thailand market estimates and forecasts, 2018 - 2030
  • Fig. 97 South Korea country dynamics
  • Fig. 98 South Korea market estimates and forecasts, 2018 - 2030
  • Fig. 99 Australia country dynamics
  • Fig. 100 Australia market estimates and forecasts, 2018 - 2030
  • Fig. 101 Latin America market estimates and forecasts, 2018 - 2030
  • Fig. 102 Brazil country dynamics
  • Fig. 103 Brazil market estimates and forecasts, 2018 - 2030
  • Fig. 104 Argentina country dynamics
  • Fig. 105 Argentina market estimates and forecasts, 2018 - 2030
  • Fig. 106 Middle East and Africa market estimates and forecasts, 2018 - 2030
  • Fig. 107 South Africa country dynamics
  • Fig. 108 South Africa market estimates and forecasts, 2018 - 2030
  • Fig. 109 Saudi Arabia country dynamics
  • Fig. 110 Saudi Arabia market estimates and forecasts, 2018 - 2030
  • Fig. 111 UAE country dynamics
  • Fig. 112 UAE market estimates and forecasts, 2018 - 2030
  • Fig. 113 Kuwait country dynamics
  • Fig. 114 Kuwait market estimates and forecasts, 2018 - 2030
  • Fig. 115 Market position of key market players- Biobanks market